706 results on '"Donath, Marc Y."'
Search Results
2. Cardiac evaluation in amiodarone-induced thyroid dysfunction with suspected cardiac ischemia?: a case report and review of the literature
3. Cystine/glutamate antiporter System xc- deficiency impairs insulin secretion in mice
4. Adiposity, immunity, and inflammation: interrelationships in health and disease: a report from 24th Annual Harvard Nutrition Obesity Symposium, June 2023
5. C-reactive protein during pregnancy and in the early postpartum predicts adverse metabolic health outcomes at 1 year postpartum in women with gestational diabetes
6. A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models
7. Inflammation in obesity, diabetes, and related disorders
8. Physiological role of cytokines in the regulation of mammalian metabolism
9. Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial
10. The cephalic phase of insulin release is modulated by IL-1β
11. Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing
12. Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome-- the FertIL trial.
13. Type 1 diabetes: what is the role of autoimmunity in [beta] cell death?
14. IL-1beta promotes the age-associated decline of beta cell function
15. Predictors of Postprandial Hypoglycemia After Gastric Bypass Surgery: a Retrospective Case-Control Study
16. Evidence for cephalic phase insulin release in humans: A systematic review and meta-analysis
17. Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study
18. Postprandial Hypoglycemia in Patients after Gastric Bypass Surgery Is Mediated by Glucose-Induced IL-1β
19. Protocol for isolation and spectral flow cytometry analysis of immune cells from the murine exocrine and endocrine pancreas
20. GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study
21. Targeting innate immune mediators in type 1 and type 2 diabetes
22. Cystine/Glutamate antiporter system xc- deficiency impairs macrophage glutathione metabolism and cytokine production
23. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes
24. IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals
25. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
26. Patient involvement to inform the design of a clinical trial in postbariatric hypoglycaemia
27. Leptin Modulates β Cell Expression of IL-1 Receptor Antagonist and Release of IL-1β in Human Islets
28. FLIP Switches Fas-Mediated Glucose Signaling in Human Pancreatic β Cells from Apoptosis to Cell Replication
29. Inhibition of IL-1beta improves Glycaemia in a Mouse Model for Gestational Diabetes
30. Nivolumab-induced diabetes mellitus--a case report with literature review of the treatment options.
31. Cystine/glutamate antiporter System xc- deficiency impairs insulin secretion in mice.
32. Proteomic Landscape of Aldosterone-Producing Adenoma
33. Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST' (Taper Or Abrupt Steroid STop) multicenter trial
34. A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models
35. Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass
36. Author Correction: A guiding map for inflammation
37. Cystine/Glutamate antiporter system xc- deficiency impairs macrophage glutathione metabolism and cytokine production.
38. Cystine/glutamate antiporter system Xc-deficiency impairs insulin secretion
39. The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
40. Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus
41. IKKβ inhibition prevents fat-induced beta cell dysfunction in vitro and in vivo in rodents
42. A guiding map for inflammation
43. Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation
44. Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing
45. Type 1 diabetes: what is the role of autoimmunity in β cell death?
46. Fractalkine (CX3CL1), a new factor protecting β-cells against TNFα
47. Mechanisms of Beta-Cell Death in Diabetes
48. Designer cytokine for the treatment of diabetes
49. Inflammation and type 2 diabetes: from basic science to treatment
50. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.